Abstract
Xanthine oxidase (XO) plays an important role in several diseases such as hyperuricemia, gout, cardiovascular and inflammation. And the XO inhibitors which can block the generation of uric acid and decrease superoxide anion in vivo show considerable promise in the therapy of these diseases. Here we present an overview of the xanthine oxidase inhibitors and also review the various analytical methods to screen xanthine oxidase inhibitors. The xanthine oxidase inhibitors can be divided into synthetic xanthine oxidase inhibitors and natural xanthine oxidase inhibitors. And both of the classical and novel analytical methods are offered.
Keywords: Analytical methods, natural xanthine oxidase inhibitors, non-purine inhibitors, purine derivatives, screening; xanthine oxidase.
Current Traditional Medicine
Title:Xanthine Oxidase Inhibitors and the Analytical Methods to Screen Them: A Review
Volume: 1 Issue: 1
Author(s): Chen Xu, Shu Liu, Fengrui Song and Zhiqiang Liu
Affiliation:
Keywords: Analytical methods, natural xanthine oxidase inhibitors, non-purine inhibitors, purine derivatives, screening; xanthine oxidase.
Abstract: Xanthine oxidase (XO) plays an important role in several diseases such as hyperuricemia, gout, cardiovascular and inflammation. And the XO inhibitors which can block the generation of uric acid and decrease superoxide anion in vivo show considerable promise in the therapy of these diseases. Here we present an overview of the xanthine oxidase inhibitors and also review the various analytical methods to screen xanthine oxidase inhibitors. The xanthine oxidase inhibitors can be divided into synthetic xanthine oxidase inhibitors and natural xanthine oxidase inhibitors. And both of the classical and novel analytical methods are offered.
Export Options
About this article
Cite this article as:
Xu Chen, Liu Shu, Song Fengrui and Liu Zhiqiang, Xanthine Oxidase Inhibitors and the Analytical Methods to Screen Them: A Review, Current Traditional Medicine 2015; 1 (1) . https://dx.doi.org/10.2174/2215083801999150527115400
DOI https://dx.doi.org/10.2174/2215083801999150527115400 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Heart Transplantation in Biventricular Congenital Heart Disease: Indications, Techniques, and Outcomes
Current Cardiology Reviews Stem Cells: Clinical Trials Results The End of the Beginning or the Beginning of the End?
Cardiovascular & Hematological Disorders-Drug Targets Altered Calmodulin Degradation and Signaling in Non-Neuronal Cells from Alzheimer’s Disease Patients
Current Alzheimer Research Cardiac Mitochondrial Alterations Observed in Hyperglycaemic Rats - What Can We Learn From Cell Biology?
Current Diabetes Reviews Current Concepts Underlying Benefits of Exercise Training in Congestive Heart Failure Patients
Current Cardiology Reviews The Role of local Insulin-like Growth Factor-1 Isoforms in the Pathophysiology of Skeletal Muscle
Current Genomics Biological Active Ingredients of Traditional Chinese Herb Astragalus membranaceus on Treatment of Diabetes: A Systematic Review
Mini-Reviews in Medicinal Chemistry Recent advances in the management of autoimmune myocarditis: insights from animal studies.
Current Pharmaceutical Design Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study
Current Pharmaceutical Design ACE2 and Diabetic Complications
Current Pharmaceutical Design Late Sodium Current Inhibition: The Most Promising Antiarrhythmic Principle in the Near Future?
Current Medicinal Chemistry Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?
Current Medicinal Chemistry Insulin- and Growth Factor-Resistance Impairs Vascular Regeneration in Diabetes Mellitus
Current Vascular Pharmacology Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy
Current Cardiology Reviews The Fabry Cardiomyopathy - Diagnostic Approach and Current Treatment
Current Pharmaceutical Design The Role of Transesophageal Echocardiography in the Intraoperative Period
Current Cardiology Reviews Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry Endothelial Cell Regulation of Cardiac Metabolism Following Diabetes
Cardiovascular & Hematological Disorders-Drug Targets